Xtant Medical Holdings (XTNT) Tops Q3 EPS by 8c

Xtant Medical Holdings (NYSE: XTNT) reported Q3 EPS of $0.07, $0.08 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $25.02 million versus the consensus estimate of $18.9 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• GE Vernova T&D India (GVTD:IN) PT Raised to INR5,300 at Emkay Global
• Citi raises Atlassian price target to $225, maintains Buy rating